UCD leading academic partner on €2.4m COVID-19 project to support new surgical technologies

Posted 30 October, 2020

• Irish medical tech firm Palliare leads EU H2020 research project with UCD Digital Surgery

UCD Digital Surgery is the lead academic partner on a new €2.4 million Covid-19 research project funded by the EU that aims to provide safer surgery solutions to healthcare staff.

UCD Digital Surgery, led by Professor (opens in a new window)Ronan Cahill from UCD School of Medicine and joined by Dr (opens in a new window)Kevin Nolan from UCD School of Mechanical and Materials Engineering, is based at the Mater Hospital and is part of UCD Centre for Precision Surgery.

The field-leading project is led nationally by medical technology company Palliare, in collaboration with University College Dublin, as well as Polish medical device manufacturer SteriPack and leading French institution for surgical training IRCAD.

The UCD team will examine the nature and extent of unintended gas leaks during surgical and non-surgical procedures such as keyhole surgery, endoscopy and intubation – where the aerosolization of body fluids poses a high risk to healthcare staff.

In general, the problem arises when small amounts of gas used during surgical procedures leak, spreading aerosols that can contain viral particles, endangering surgeons and depositing the virus on operating room surfaces.

The goal of PORSAV is to develop two novel medical devices to manage and filter such leaks at source, and enable the mass production and distribution of the devices to surgical teams and Covid-19 care teams worldwide.

The work applies learning from UCD’s airflow-in-surgery research and will benefit from the foundations laid in data sharing and digital analytics between UCD and the Mater Hospital through the Digital Surgery Unit.

Leveraging Dr Kevin Nolan’s optical expertise, the UCD team will develop portable, innovative imaging technology for the operating room, to accurately characterise and measure the potentially hazardous invisible gas leaks.

They will then carry out clinical trials in conjunction with the Mater Hospital to test Palliare’s new devices in real time.

Palliare’s devices includes a vacuum ring called LeakTrapTM which captures stray air leaks that occur around the edge of the keyhole surgery tube or the incision, and pipes potentially infectious air away for correct disposal. And a similar device called the EndoTrapTM which protects gastroenterologists performing endoscopies from the breath, coughing or sneezing of their patients.

The PORSAV project will produce thousands of LeakTraps and EndoTraps to be used in operating rooms around the world.

Palliare co-founder, John O’Dea said: “For several months after the pandemic started, surgical procedures stopped due to concerns around risks to hospital staff from aerosolized virus. We are delighted to have assembled such an outstanding multi-disciplinary team and are grateful to the European Commission for the support to conduct this research and development project aiming to make surgery safer during this and future pandemics. Surgery can’t stop.

“Our experience in Med Tech innovation has always been that the progress of any significant medical device hinges on the collaboration of passionate clinicians and passionate engineers.

“Palliare has found such a passion for clinical innovation in surgery and for active publication in Professor Ronan Cahill at UCD and Professors Perretta and Dallemagne at IRCAD in Strasbourg. We are excited about moving forward in researching and trialling new surgical devices with these innovative physicians.”

Consultant Colorectal Cancer Surgeon, Professor Ronan Cahill said: “It’s fantastic that a real, tangible solution to the fundamental problem we have characterised can now be delivered via the very talented engineering and commercial team John O’Dea leads at Palliare, as well as with the other consortium partners, IRCAD and Steripak.

“The team at UCD have worked intensely in this space, with Dr Kevin Nolan in a central role. Alongside our surgical insights and expertise, this produced some really remarkable work at a time of great societal difficulty.

“This project confirms the Mater Hospital as a leading applied clinical research partner for surgical practice advances – both the background work and the next iterative phases could really only be done at this exceptional surgical facility. The award is another great endorsement of our unique capabilities in cross-sectoral innovation for better surgery.”

Beyond Covid, the research will also improve safety and efficiency in anaesthesia, in critical care intubation and other invasive procedures – including offering a supplementary solution to the chronic problem of surgical smoke inhalation by surgeons and nurses.

In addition, it has applications outside of medicine for managing gas leaks in other contexts.

Projects partners Professor Bernard Dallemagne and Professor Silvana Perretta will direct a second trial at IRCAD in France and will use the new technology and information to train surgeons around the world on how to reduce the risks of COVID-19 in the operating room.

SteriPack will mass-produce the disposable tubing in Poland, while the vacuum technology is manufactured by Palliare in Galway. Pintail Ltd will provide project management and administrative support.

The PORSAV (Protection of Operating Room Staff from Aerosolized Virus) consortium project is funded under the EU’s Horizon 2020 programme.

By: Staff Writers (with materials from Caroline Byrne, UCD Research and Innovation)